Christopher H. Lieu
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 76
- Pancreatic and Hepatic Oncology Research 25
- Cancer Immunotherapy and Biomarkers 25
- Colorectal Cancer Screening and Detection 15
- Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 47
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 31
- Hepatology top 2%
-
- Gastric Cancer Management and Outcomes 22
- Lung Cancer Treatments and Mutations 14
Christopher H. Lieu
162 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 3.3k
- Pathology and Forensic Medicine 1.5k
- Cancer Research 1.1k
- Hepatology 423
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Christopher H. Lieu
This map shows the geographic impact of Christopher H. Lieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher H. Lieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher H. Lieu more than expected).
Fields of papers citing papers by Christopher H. Lieu
This network shows the impact of papers produced by Christopher H. Lieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher H. Lieu. The network helps show where Christopher H. Lieu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher H. Lieu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 7 | |
| 13 | Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Updatebreakdown → | 2021 | 155 |
| 14 | 2019 | 135 | |
| 15 | 2019 | 149 | |
| 16 | 2019 | 3 | |
| 17 | 2017 | 9 | |
| 18 | 2015 | 118 | |
| 19 | The impact of young age on survival in patients with metastatic colorectal cancer: Analysis from the ARCAD Clinical Trials Program | 2013 | 3 |
| 20 | 2011 | 84 |
About Christopher H. Lieu
Christopher H. Lieu is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 173 papers that have together received 5.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (76 papers), Genetic factors in colorectal cancer (47 papers), Cancer Genomics and Diagnostics (31 papers), Pancreatic and Hepatic Oncology Research (25 papers), Cancer Immunotherapy and Biomarkers (25 papers), Gastric Cancer Management and Outcomes (22 papers), Colorectal Cancer Screening and Detection (15 papers) and Lung Cancer Treatments and Mutations (14 papers). The work is most often cited by research in Oncology (3.3k citations), Pathology and Forensic Medicine (1.5k citations) and Cancer Research (1.1k citations). Christopher H. Lieu has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Scott Kopetz, Michael J. Overman, John V. Heymach, Hai T. Tran, Swati Patel, C. Richard Boland, Jordan J. Karlitz, Timothy Yen, Cathy Eng and Dipen M. Maru. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.